
Enzo Biochem ENZ
Quartalsbericht 2024-Q3
hinzugefügt 16.12.2024
Enzo Biochem EV/EBITDA 2011-2026 | ENZ
EV/EBITDA Jährlich Enzo Biochem
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 58.3 | -3.16 | -4.63 | -40.9 | 205 | -8.52 K | -1.33 K | -100 | -10.3 | -4.91 | -12.1 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 205 | -8.52 K | -888 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 22.96 | -0.56 % | $ 99.4 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Danaher Corporation
DHR
|
20.1 | $ 237.64 | 1.12 % | $ 174 B | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 12.15 | -5.81 % | $ 345 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 23.25 | -0.66 % | $ 250 M | ||
|
DexCom
DXCM
|
39.5 | $ 66.95 | -2.16 % | $ 25.8 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.59 | -0.94 % | $ 2.02 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 6.12 | - | $ 180 M | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 243.33 | 0.06 % | $ 44.1 B | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 39.59 | -0.76 % | $ 1.1 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
-19.5 | $ 234.65 | -2.05 % | $ 23.1 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.02 | -1.16 % | $ 915 M | ||
|
Celcuity
CELC
|
-2.38 | $ 107.43 | 2.63 % | $ 4.24 B | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.95 | -4.66 % | $ 495 M | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 3.41 | -0.29 % | $ 109 K | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 102.13 | 0.34 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 27.84 | -0.2 % | $ 842 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | $ 48.32 | -0.27 % | $ 10.8 B | ||
|
RadNet
RDNT
|
17.6 | $ 77.42 | -1.22 % | $ 5.65 B | ||
|
Guardant Health
GH
|
-28.8 | $ 110.18 | 1.32 % | $ 13.5 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 141.01 | -3.31 % | $ 22.4 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 220.64 | 2.38 % | $ 11.3 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 620.69 | 2.34 % | $ 237 B | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.73 | -1.13 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 35.58 | 2.42 % | $ 2.13 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 175.1 | -1.49 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 5.46 | -2.15 % | $ 708 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 252.61 | -0.81 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 183.13 | -2.7 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 715.47 | 0.43 % | $ 59 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 67.98 | 0.19 % | $ 4.7 B | ||
|
Agilent Technologies
A
|
27.4 | $ 148.92 | 2.17 % | $ 45.3 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.75 | -4.84 % | $ 6.32 M | ||
|
Bioventus
BVS
|
26.4 | $ 8.02 | 0.25 % | $ 502 M |